AVAI BIO INC. (AVAI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AVAI Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding AVAI BIO INC.'s financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.08
Cash & Short-term Investments0.00
Accounts receivable0.06
Total loans net0.01
Total Current Assets0.15
Equipment/Property/Plant Net0.00
Intangible Assets0.16
Long-term investments0.12
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.01
Other Assets, Noncurrent0.34
Total Assets0.79
Liabilities
Accounts Payable1.73
Short-term Debt0.00
Other Liabilities, Current1.03
Total Current Liabilities4.01
Long-term debt0.76
Total Long-term Debt0.76
Other liabilities, Noncurrent0.50
Total Liabilities4.01
Stockholders' Equity
Common Stock Value0.15
Additional Paid In Capital Common Stock3.02
Retained Earnings / Accumulated Deficit-6.42
Common Stockholder's Equity-3.25
Preferred Stockholder's Equity0.03
Total Stockholder's Equity-3.22
Liabilities & Stockholder's Equity0.79
4 historic quarters locked

Sign in to unlock the full AVAI BIO INC. balance sheet history.

About Avai Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001740797-26-000021

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.